Step into Zhuoyi
Warmly celebrate Zhuoyi Bio’s inclusion on the 2025 Jilin Province Manufacturing Single-Champion Enterprise Public List.
Release Date:
2025-09-30
- About Zhuoyi Bio -
Zhuoyi uses human‑derived strains, ensuring greater efficacy with a shared origin; Zhuoyi employs Vero cells, offering enhanced safety by eliminating tumor‑forming risks; Zhuoyi features VVM labeling, providing visible assurance of safety and effectiveness; and Zhuoyi’s rabies vaccine is patented, with zero added antibiotics for added peace of mind.
Zhuoyi Biologics adheres to the philosophy of “Healthier, More Professional,” and is committed to becoming a global vaccine manufacturer that delivers superior quality, broad accessibility, and sustainable development, contributing Zhuoyi’s strength to Healthy China and the advancement of global public health.